• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,755.05 -715.06
( -0.92%)
Global Indices
Nasdaq
52,245.67 385.41
(0.74%)
Dow Jones
7,529.66 65.38
(0.88%)
Hang Seng
66,164.55 -67.64
(-0.10%)
Nikkei 225
10,722.03 136.12
(1.29%)
Forex
USD-INR
96.43 0.01
(0.01%)
EUR-INR
110.17 -0.09
(-0.08%)
GBP-INR
129.67 0.03
(0.02%)
JPY-INR
0.59 0.00
(0.01%)

Corporate Actions - Latest Board Meetings

EQUITY - MARKET SCREENER

Company Name Date Purpose
Cipla 23-Jul-26 Cipla Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2026 inter alia to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30th June 2026. In terms of the Companys Code of Conduct for prevention of Insider Trading the Trading window for dealing in the securities of the Company will be closed from Wednesday 1st July 2026 till Saturday 25th July 2026 (both days inclusive) for the purpose of financial results.
C P C L 23-Jul-26 Chennai Petroleum Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2026 inter alia to consider and approve Audited Financial Results For The Quarter Ended 30th June 2026 (Q1)
Infosys 23-Jul-26 Infosys Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2026 ,inter alia, to consider and approve 1. Approve and take on record the audited consolidated financial results of the Company and its subsidiaries as per Indian Accounting Standards (INDAS) for the quarter ending June 30, 2026; 2. Approve and take on record the audited standalone financial results of the Company as per INDAS for the quarter ending June 30, 2026; 3. Approve and take on record the audited financial statements of the Company and its subsidiaries as per INDAS and IFRS for the quarter ending June 30, 2026. Infosys Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2026 ,inter alia, to consider and approve 1. Approve and take on record the audited consolidated financial results of the Company and its subsidiaries as per Indian Accounting Standards (INDAS) for the quarter ending June 30, 2026; 2. Approve and take on record the audited standalone financial results of the Company as per INDAS for the quarter ending June 30, 2026; 3. Approve and take on record the audited financial statements of the Company and its subsidiaries as per INDAS and IFRS for the quarter ending June 30, 2026 (As Per BSE Announcement Dated on : 15.06.2026)
Prime Securities 23-Jul-26 Prime Securities Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2026 inter alia to consider and approve Approval of Unaudited Financial Results for the Quarter ended June 2026
Novartis India 23-Jul-26 Quarterly Results Novartis India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2026 ,inter alia, to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2026.
Jamshri Realty 23-Jul-26 Jamshri Realty Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2026 inter alia to consider and approve Pursuant to Regulation 29(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that a meeting of the Board of Directors of the Company will be held on Thursday 23rd July 2026 inter alia to consider and approve the Unaudited (Standalone) financial results of the Company for the quarter ended 30th June 2026. Trading window closure : Further in accordance with the Companys Code for Prevention of Insider Trading the Trading Window for dealing in the Companys securities was closed from Wednesday July 1 2026 and will open 48 hours after declaration of the said results. Thanking you Yours faithfully For Jamshri Realty Limited. (RAJESH DAMANI ) Joint Managing Director
Alna Trading 23-Jul-26 Alna Trading & Exports Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2026 inter alia to consider and approve 1. To consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30 2026 together with the Limited Review Report thereon. 2. To consider and approve the convening of the Forty-Fourth Annual General Meeting (AGM) of the Company for the Financial Year 2025-26 and matters incidental thereto including the approval of the Notice convening the AGM and the Annual Report of the Company for the Financial Year 2025-26. 3. To consider and approve the Book Closure dates and the Cut-off Date for the purpose of the Forty-Fourth AGM and remote e-voting if applicable. 4. To consider and approve the appointment of the Scrutinizer for conducting the remote e-voting process and voting at the Forty-Fourth AGM. 5. To consider any other business with the permission of the Chair.
Coromandel Inter 23-Jul-26 Coromandel International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2026 inter alia to consider and approve Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended June 30 2026.
GRP 23-Jul-26 GRP Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2026 inter alia to consider and approve to consider and approve the unaudited financial results (Standalone & Consolidated) of the Company for the quarter ended 30th June 2026.
Cemindia Project 23-Jul-26 Cemindia Projects Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a meeting of the Board of Directors of the Company will be held on Thursday, 23rd July. 2026 to, inter-alia, consider proposal(s) for raising of funds by way of issuance equity shares or any other eligible securities through permissible modes, including but not limited to a private placement, a qualified institutions placement, preferential issue, or any other method or combination of methods as may be permitted under applicable laws, in one or more tranches, subject to shareholders' approval and such regulatory/statutory approvals as may be required.
<< < 1 2 3  ... > >>